Home
>
National Drug Code (NDC)
>
Clindamycin Phosphate
Clindamycin Phosphate - 54868-3695-0 - (clindamycin phosphate)
Drug Information of Clindamycin Phosphate
| Product NDC: | 54868-3695 |
| Proprietary Name: | Clindamycin Phosphate |
| Non Proprietary Name: | clindamycin phosphate |
| Active Ingredient(s): | 150 mg/mL & nbsp; clindamycin phosphate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Clindamycin Phosphate
| Product NDC: | 54868-3695 |
| Labeler Name: | Physicians Total Care, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA062801 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19970227 |
Package Information of Clindamycin Phosphate
| Package NDC: | 54868-3695-0 |
| Package Description: | 1 TRAY in 1 CASE (54868-3695-0) > 25 VIAL, SINGLE-DOSE in 1 TRAY > 2 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of Clindamycin Phosphate
| NDC Code | 54868-3695-0 |
| Proprietary Name | Clindamycin Phosphate |
| Package Description | 1 TRAY in 1 CASE (54868-3695-0) > 25 VIAL, SINGLE-DOSE in 1 TRAY > 2 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 54868-3695 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clindamycin phosphate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 19970227 |
| Marketing Category Name | ANDA |
| Labeler Name | Physicians Total Care, Inc. |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Strength Number | 150 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |
